central Venous Access Catheters


Maximal Barrier Precautions KitClinicians like you asked Arrow to meet your needs. When you required a total, proven infection risk reduction solution, Arrow delivered. You asked for a wider array of catheter lengths, flow rates and customizable kits---and we gave you the broadest range of catheters in the industry. The bottom line: Arrow never stops working to engineer products that earn the trust of you and your patients.


Arrow offers one of the industry's most comprehensive ranges of CVCs and related products: from ARROWg+ard® catheters and uncoated catheters to scores of unique comprehensive kits that include an array of options, such as large barrier drape, ChloraPrep® and safety needles.


Arrow pioneered the antimicrobial-impregnated cathteter (our ARROWg+ard technology) in 1990. No other company's catheter has such a strong track record and broad spectrum of activity. In fact, over 30 studies and reviews prove ARROWg+ard catheter technology's ability to decrease the incidence of catheter-related bloodstream infection (CRBSI), reduce cost and save lives.1

ARROWg+ard reduces bacterial colonization of the catheter by 60 percent and catheter-related bacteremia by an even greater 80 percent.2 And it has been proven effective against a wide array of gram-positive bacteria, including S. epidermidis, MRSA and S. aureus; gram-negative bacteria, including Enterorocci and Pseudomonas strains; and fungi, including C. albicans.3

Now our latest breakthrough, ARROWg+ard Blue PLUS®, gives you that proven infection-fighting ability both outside and in, including extension lines and hubs. With ARROWg+ard Blue PLUS chlorahexidine and silver sulfadiazine continuously prep the subcutaneous catheter tract and kill organisms in places that you simply can't reach.


See also:

For more information, contact Arrow Customer Service.



1Veenstra, D.L., Saint, S., Saha, S., Lumley, T., Sullivan, S.D. "Cost-Effectiveness of Antiseptic-Impregnated Central Venous Catheters for the Prevention of Catheter-Related Bloodstream Infection," Journal of the American Medical Association, January 20, 1999, Vol. 281, Issue 3, pp. 261-267.

2Maki, D.G., Stolz, S.M., Wheeler, S., Mermel, L.A. “Prevention of Central Venous Catheter-Related Bloodstream Infection With an Antiseptic-Impregnated Catheter: A Randomized, Controlled Trial,” Annals of Internal Medicine, August 15, 1997, Vol. 127, Issue 4, pp. 257–266.

3References include but are not limited to Maki 1997, Sampath 1995 and Bach 1994.


ChloraPrep® is a registered trademark of Medi-Flex, Inc.